Portola Pharmaceuticals (PTLA)

Earnings in 2020 (TTM): -€0.23 Billion

According to Portola Pharmaceuticals 's latest financial reports the company's current earnings are €0.12 Billion. In 2019 the company made an earning of -€0.23 Billion, an increase over its 2018 earnings that were of -€0.29 Billion.

Earnings history for Portola Pharmaceuticals from 2012 to 2020

Annual earnings

Year	Earnings	Change
2020 (TTM)	-€0.23 Billion	0.53%
2019	-€0.23 Billion	-21.16%
2018	-€0.29 Billion	21.74%
2017	-€0.24 Billion	1.1%
2016	-€0.23 Billion	18.67%
2015	-€0.2 Billion	65.14%
2014	-€0.12 Billion	65.04%
2013	-€70.64 Million	-833.35%
2012	€9.63 M

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Johnson & Johnson JNJ	€27.45 B	-13,141.40%	🇺🇸 USA
Pfizer PFE	€10.04 B	-4,871.16%	🇺🇸 USA
Sanofi SNY	€7.71 B	-3,763.42%	🇫🇷 France
Biogen BIIB	€1.61 B	-866.48%	🇺🇸 USA
Bristol-Myers Squibb BMY	€6.80 B	-3,333.78%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Portola Pharmaceuticals (PTLA)

Earnings in 2020 (TTM): -€0.23 Billion